Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Net Income Summary of Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited's latest annual net income in 2023 was -674.36 Million CNY , up 7.67% from previous year.
Genor Biopharma Holdings Limited's latest quarterly net income in 2024 Q2 was -62.84 Million CNY , down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported an annual net income of -730.39 Million CNY in 2022, up 15.6% from previous year.
Genor Biopharma Holdings Limited reported an annual net income of -865.37 Million CNY in 2021, up 71.44% from previous year.
Genor Biopharma Holdings Limited reported a quarterly net income of -62.84 Million CNY for 2024 Q1, up 68.56% from previous quarter.
Genor Biopharma Holdings Limited reported a quarterly net income of -137.27 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Genor Biopharma Holdings Limited (2023 - 2018)

Historical Annual Net Income of Genor Biopharma Holdings Limited (2023 - 2018)

Year	Net Income	Net Income Growth
2023	-674.36 Million CNY	7.67%
2022	-730.39 Million CNY	15.6%
2021	-865.37 Million CNY	71.44%
2020	-3.03 Billion CNY	-479.73%
2019	-522.74 Million CNY	-80.5%
2018	-289.61 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-62.84 Million CNY	0.0%
2024 Q1	-62.84 Million CNY	68.56%
2023 Q2	-137.27 Million CNY	0.0%
2023 Q4	-199.9 Million CNY	0.0%
2023 Q3	-199.9 Million CNY	-45.62%
2023 FY	-674.36 Million CNY	7.67%
2023 Q1	-137.27 Million CNY	15.41%
2022 Q3	-162.29 Million CNY	19.98%
2022 Q2	-202.81 Million CNY	0.0%
2022 Q1	-202.81 Million CNY	12.64%
2022 FY	-730.39 Million CNY	15.6%
2022 Q4	-162.29 Million CNY	0.0%
2021 Q1	-200.44 Million CNY	83.92%
2021 FY	-865.37 Million CNY	71.44%
2021 Q4	-232.16 Million CNY	0.0%
2021 Q3	-232.16 Million CNY	-15.82%
2021 Q2	-200.44 Million CNY	0.0%
2020 Q1	-142.51 Million CNY	0.0%
2020 Q4	-1.24 Billion CNY	0.0%
2020 Q3	-1.24 Billion CNY	-218.02%
2020 Q2	-392.07 Million CNY	-175.1%
2020 FY	-3.03 Billion CNY	-479.73%
2019 FY	-522.74 Million CNY	-80.5%
2019 Q1	-74.88 Million CNY	0.0%
2018 FY	-289.61 Million CNY	0.0%

Peer Net Income Comparison of Genor Biopharma Holdings Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	1051.467%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	4009.345%